Please try another search
For the six months ended 30 June 2018, Polmed SA revenues increased 17% to PLN62.3M. Net income applicable to common stockholders increased from PLN2.2M to PLN5.2M. Revenues reflect Sale of Goods & Materials increase of 17% to PLN358K. Net income benefited from Interest Expense decrease of 20% to PLN57K (expense), Compensations Received increase of 100% to PLN14K (income).
Period Ending: | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|
Total Revenue | 31.16 | 31.1 | 28.79 | 27.72 |
Gross Profit | 4.62 | 4.7 | 3.39 | 3.57 |
Operating Income | 3.25 | 3.61 | 2.47 | 2.58 |
Net Income | 2.42 | 2.73 | 1.86 | 1.96 |
Period Ending: | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|
Total Assets | 66.01 | 67.74 | 61.62 | 59.46 |
Total Liabilities | 17.39 | 21.71 | 18.33 | 18.03 |
Total Equity | 48.62 | 46.02 | 43.29 | 41.43 |
Period Ending: | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -2.52 | 4.79 | 8.13 | 4.54 |
Cash From Investing Activities | -0.55 | -0.25 | -0.5 | -0.15 |
Cash From Financing Activities | -1.74 | -0.54 | -5.27 | -5.11 |
Net Change in Cash | -4.81 | 4 | 2.36 | -0.73 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review